期刊文献+

p65结合肽与p65的亲和力检测及其对NF-κB DNA结合活性抑制作用的鉴定 被引量:1

Determination of affinities of oligopeptides binding with p65 and identification of their inhibiting effect on DNA binding activity of NF-κB
下载PDF
导出
摘要 目的检测NF-κB p65亚基结合肽与p65间相互作用的亲和常数,以及其对NF-κB DNA结合活性的抑制效应。方法借助于生物传感器技术分析NF-κB p65亚基结合肽与p65相互作用的动力学,同时应用竞争性ELISA鉴定结合多肽对NF-κB DNA结合活性的抑制效应。结果生物传感器技术分析结果表明5条p65结合肽均能与p65发生相互作用,相互作用的亲和常数分别为GST-BPT1:2.67×10-7mol/L、GST-BPT2:9.02×10-6mol/L、GST-BPT3:1.07×10-6mol/L、GST-BPT4:8.03×10-6mol/L、GST-BPT5:9.83×10-7mol/L。竞争性ELISA检测结果表明5条p65结合肽均能在一定程度上抑制NF-κB与其顺式作用元件κB基序的结合,且这种抑制效应随多肽浓度的增加而增强。结论酵母双杂交筛选获得的5条p65结合多肽与p65间确实存在相互作用,且5条结合肽对NF-κB DNA结合活性均有一定的抑制效应,由此提示以这些多肽为先导物设计和开发靶向NF-κB的抗炎多肽药物将成为可能。 Objective To determine the affinities of five oligopeptides specifically binding with DNA binding domain of NF-κB 1365 subunit and identify their inhibiting effect on DNA binding activity of NF-κB. Methods By using biosensor the affinities were measured by means of kinetic analysis, and the inhibiting effects were determined by competitive ELISA. Results The results of biosensor showed that all of five oligopeptides really possessed the capability of specific interacting with NF-κB p65 subunit. The affinity constants of these oligopeptides were 2.67 ×10^-7 mol/L, 9.02 ×10^-6 mol/L, 1.07 ×10^-6 mol/L, 8.03 ×10^-6 mol/L, 9.83 ×10^-7 mol/L respectively. The results of competitive ELISA indicated that five oligopeptides could inhibit NF-κB from binding with KB motif, and their inhibiting effect depended on their concentration. Conclusion Five oligopeptides that were screened by yeast two-hybrid system method can really interact with 1365, and possess the inhibiting effect on DNA binding activity of NF-κB. So it will be possible that these oligopeptides are regarded as model to design and develop novel anti-inflammatory peptide drug targeting NF-κB.
出处 《第三军医大学学报》 CAS CSCD 北大核心 2006年第7期621-625,共5页 Journal of Third Military Medical University
基金 国家重点基础研究发展规划资助项目("973"项目)(G1999054203) 国家自然科学基金资助项目(30080009 30200270) 全军医学科研"十五"计划面上项目(01MB113)~~
关键词 NF-ΚB P65 生物传感器 多肽 NF-κB p65 biosensor oligopeptide
  • 相关文献

参考文献12

  • 1SEN R,BALTIMORE D.Inducibility of kappa immunoglobulin enhancer-binding protein Nf-kappa B by a posttranslational mechanism[J].Cell,1986,47(6):921 -928.
  • 2WRIGHT J G,CHRISTMAN J W.The role of nuclear factor kappa B in the pathogenesis of pulmonary diseases:implications for therapy[J].Am J Respir Med,2003,2(3):211 -219.
  • 3YAMAMOTO Y,GAYNOR R B.Therapeutic potential of inhibition of the NF-kappaB pathway in the treatment of inflammation and cancer[J].J Clin Invest,2001,107(2):135 -142.
  • 4TAS S W,REMANS P H,REEDQUIST K A,et al.Signal transduction pathways and transcription factors as therapeutic targets in inflammatory disease:towards innovative antirheumatic therapy[J].Curr Pharm Des,2005,11(5):581 -611.
  • 5BARNES P J.Anti-inflammatory actions of glucocorticoids:molecular mechanisms[J].Clin Sci (Lond),1998,94(6):557-572.
  • 6MENG L,MOHAN R,KWOK B H,et al.Epoxomicin,a potent and selective proteasome inhibitor,exhibits in vivo antiinflammatory activity[J].Proc Natl Acad Sci USA,1999,96(18):10403 -10408.
  • 7AGGARWAL B B,TAKADA Y,SHISHODIA S,et al.Nuclear transcription factor NF-kappa B:role in biology and medicine[J].Indian J Exp Biol,2004,42(4):341 -353.
  • 8李生茂,梁华平,徐祥,刘东擘.GST Pull-down实验鉴定NF-κB相互作用多肽[J].免疫学杂志,2006,22(1):94-97. 被引量:5
  • 9DUNN D L.Prevention and treatment of multiple organ dysfunction syndrome:lessons learned and future prospects[J].Surg Infect(Larchmt),2000,1(3):227 -237.
  • 10MARUMO T,SCHINI-KERTH V B,BUSSE R.Vascular endothelial growth factor activates nuclear factor-kappaB and induces monocyte chemoattractant protein-1 in bovine retinal endothelial cells[J].Diabetes,1999,48(5):1131-1137.

二级参考文献12

  • 1Hoffmann A,Levchenko A,Scott ML,et al.The ikappaBNF-kappaB signaling module:temporal control and selective gene activation[J].Science,2002,298 (5 596):1 241-1 245.
  • 2Lin L,Spoor MS,Gerth AJ,et al.Modulation of Th1 activation and inflammation by the NF-kappaB repressor Foxj1[ J].Science,2004,303 (5 660):1 017-1 020.
  • 3Lopez Franco O,Suzuki Y,Sanjuan G,et al.Nuclear factor-kappa B inhibitors as potential novel anti-inflammatory agents for the treatment of immune glomerulonephritis[ J ].Am J Pathol,2002,161 (4):1 497-1 505.
  • 4Yamamoto Y,Gaynor RB.Therapeutic potential of inhibition of the NF-κB pathway in the treatment of inflammation and cancer[J].J Clin Invest,2001,107 (2):135-142.
  • 5Brent R,Ptashne M.A eukaryotic transcriptional activator bearing the DNA specificity of a prokaryotic repressor[ J ].Cell,1985,43(3 Pt 2),729-736.
  • 6Benard V,Bokoch GM.Assay of Cdc42,Rac,and Rho GTPase activation by affinity methods[ J].Methods Enzymol,2002,345:349-359.
  • 7Chai J,Du C,Wu JW,et al.Structural and biochemical basis of apoptotic activation by Smac/DIABLO[ J ].Nature,2000,406 (6 798),855-862.
  • 8Huang LJ,Constantinescu SN,Lodish HF.The N-terminal domain of Janus kinase 2 is required for Golgi processing and cell surface expression of erythropoietin receptor[J].Mol Cell,2001,8(6):1 327-1 338.
  • 9Gruber TM,Markov D,Sharp MM,et al.Binding of the initiation factor sigma(70) to core RNA polymerase is a multistep process[J].Mol Cell,2001,8 (1):21-31.
  • 10Bottero V,Rossi F,Samson M,et al.Ikappa b-alpha,the NF-kappa B inhibitory subunit,interacts with ANT,the mitochondrial ATP/ADP translocator[J].J Biol Chem,2001,276 (24):21 317-21 324.

共引文献16

同被引文献25

  • 1卓佳,陈柏坤,薛向阳,张丽芳.核因子-κBp65和IκB-α在宫颈癌中的表达及意义[J].温州医学院学报,2005,35(3):182-184. 被引量:4
  • 2Lin Y, Bai L, Chen W, et al. The NF-kappaB activation pathways, emerging molecular targets for cancer prevention and therapy[J]. Expert Opin Ther Targets,2010,14(1): 45-55.
  • 3Baud V, Karin M. Is NF-kappaB a good target for cancer therapy? Hopes and pitfalls[J]. Nat Rev Drug Discov,2009,.
  • 4Sethi G, Sung B, Aggarwal BB. Nuclear factor-kappaB activation: from bench to bedside[J]. Exp Biol Med,2008, 233(1):21-31.
  • 5Kriete A, Mayo KL. Atypical pathways of NF-kappaB activation and aging[J]. Exp Gerontol,2009,44(4):250-255.
  • 6Muthusamy V, Piva TJ. The UV response of the skin:a review of the MAPK, NFkappaB and TNFalpha signal trans- duction pathways[J]. Arch Dermatol Res, 2010,302(1):5- 17.
  • 7Phelps CB, Ghosh G. Discreet mutations from c-Rel to vRel alter kappaB DNA recognition, IkappaBalpha binding, and dimerization: implications for v-Rel oncogenicity[J]. Oncogene,2004,23(6): 1229-1238.
  • 8Wei L, Liu J. Porcine circovirus type 2 replication is impaired by inhibition of the extracellular signal-regulated ki- nase (ERK) signaling pathway[J]. Virology,2009,386(1):203- 209.
  • 9Johmura Y, Suzuki M, Osada S, et al. FAD24, a regulator of adipogenesis and DNA replication, inhibits H-RAS-mediated transformation by repressing NF-kappaB activity[J]. Biochem Biophys Res Commun,2008,369(2):464-470.
  • 10Reuter S, Charlet J, Juncker T,et al. Effect of curcumin on nuclear factor kappaB signaling pathways in human chronic myelogenous K562 leukemia cells[J]. Ann N Y Acad Sci, 2009,1171(8):436-447.

引证文献1

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部